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RESEARCH ARTICLE Open Access
Pre-pregnancy counselling for women with
chronic kidney disease: a retrospective analysis of
nine years’ experience
Kate S Wiles1,2*, Kate Bramham1,2, Alina Vais1, Kate R Harding1, Paramit Chowdhury1, Cath J Taylor2
and Catherine Nelson-Piercy1,3
Abstract
Background: Women with chronic kidney disease have an increased risk of maternal and fetal complications in
pregnancy. Pre-pregnancy counselling is recommended but the format of the counselling process and the
experience of the patient have never been assessed. This study examines the experience of women with chronic
kidney disease attending pre-pregnancy counselling and evaluates their pregnancy outcomes.
Methods: This is a cross-sectional assessment of 179 women with chronic kidney disease attending a pre-pregnancy
counselling clinic (2003–2011) with retrospective evaluation of aetiology, comorbidity, treatment and adverse
pregnancy outcome compared with 277 hospital controls. It includes an analysis of descriptive data and free text
content from 72 questionnaire responders.
Results: 65/72 (90%) of women found the clinic informative. 66 women (92%) felt that the consultation had helped
them decide about pursuing pregnancy. 12 women (17%) found the multidisciplinary process intimidating. Free text
comments supported the positive nature of the counselling experience, but also highlighted issues of access and
emotional impact. Adverse pregnancy outcome rates were significantly higher in women with chronic kidney disease:
7/35 (20%) had pre-eclampsia (p < 0.001), 8/35 (23%) infants were small for gestational age (p < 0.001), 11/35 (31%) had
preterm deliveries (<37 weeks) (p < 0.001) and 5/35 (14%) had a pregnancy loss compared with 4%, 10%, 8% and 3%
of controls respectively.
Conclusions: Women with a diverse range of renal disease severity and complexity attend pre-pregnancy counselling.
Factors affecting pregnancy include hypertension, proteinuria and teratogenic medication. It is important to be able to
inform women of the risks to them and their babies before pregnancy in order to facilitate informed-decision making.
Most women with chronic kidney disease attending a pre-pregnancy counselling clinic report a positive experience.
Keywords: Chronic kidney disease (CKD), Pregnancy, Counselling, Experience, Multidisciplinary
Background
All pregnant women with chronic kidney disease (CKD)
are at increased risk of maternal and fetal complications
including pre-eclampsia, fetal growth restriction, pre-
term delivery, perinatal death and acceleration of mater-
nal disease [1]. A systematic review reports that women
with CKD have a two-fold increased risk of adverse fetal
outcomes and a five-fold risk of an adverse maternal
event [2]. These adverse events are substantially more
common than for most other chronic diseases and yet
women with CKD may be unaware that their condition
has implications for pregnancy [3].
Meta-analysis data on pregnancy outcomes in CKD [4]
have led to recommendations for evidence-based con-
temporaneous pre-pregnancy counselling, supported by
guidelines from the Royal College of Obstetricians and
Gynaecologists [5]. Furthermore, the confidential enquiry
into maternal deaths in the UK recommended that pre-
pregnancy counselling should be provided for women
with pre-existing medical illnesses, in response to the
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identification of maternal mortality in women who had
not received pre-pregnancy advice [6].
Pre-pregnancy counselling offers an opportunity to ad-
just medication, optimise blood pressure, quantify
proteinuria and educate women about potential adverse
events that may arise during, or develop as a conse-
quence of pregnancy [7]. However, methods of pre-
pregnancy counselling for women with CKD and its
acceptability to women have never been examined. The
aim of this study was to evaluate the experience of women
with CKD who have received pre-pregnancy counselling
at an established tertiary clinic. In addition, pregnancy
outcomes of the counselled cohort women were com-
pared with a control population delivering in the same ter-
tiary unit in order to better inform the counselling process
in the future.
Methods
The multi-disciplinary pre-pregnancy clinic for women
with CKD, including renal transplant recipients, was
established at Guy’s and St. Thomas’ NHS Foundation
Trust in 1999. Referrals are received from nephrologists,
obstetricians and general practitioners predominantly
from London and South East England. Women are seen
by a consultant obstetric physician, specialist obstetri-
cian, and a nephrologist for a combined consultation
lasting 30–45 minutes. Women’s partners are invited
to attend. Individualised, evidence-based counselling is
given to women considering pregnancy. The potential
outcomes of pregnancy, mode of delivery and the short
term and long-term impact on maternal renal function
are described in detail. Drug regimens are reviewed for
potential teratogenicity; the risks and benefits of dis-
continuing drugs prior to or following conception is
outlined, and recommendations for low dose aspirin
prophylaxis [7] are discussed. Local or tertiary antenatal
care and delivery are planned. Contraceptive counselling
and advice regarding pre-conception folic acid is given.
Women and their partners are offered the opportunity
to ask any questions or request clarification about the
counselling. A comprehensive letter is sent to the refer-
ring doctor, the general practitioner and the patient do-
cumenting the advice given.
Women’s experiences of the clinic were examined using
a questionnaire developed by the authors. In 2001, the
Institute of Medicine identified the different dimensions
that constitute patient-centred care [8]. This framework
was used to inform the structure and content of the
questionnaire which was further determined by expert
consensus from the service providers. The questionnaire
examines women’s views regarding their involvement, ex-
tent of shared decision-making, and quality/usefulness of
information and communication. A four-point response
scale was used to maximise variability and avoid
responses set to the midpoint [9]. Descriptive anchors ra-
ther than a scored response were recorded to prevent
homogenous interpretation of the data due to interval
scale assumption. The questionnaire was anonymised to
encourage response and candour.
The questionnaire was piloted in 2002 and sent to 62
women. 30 women responded (48%). This confirmed
that the patients were using the full range of possible an-
swers and that the distribution was not disproportion-
ately skewed. Invited free text responses were used to
assess the adequacy of the included questions. Following
this pilot, a final questionnaire was devised including 9
fixed, closed-format questions (see Additional file 1:
Table S1). In addition, free text responses were invited
with the lead ‘Do you have any other comments about
your experience in the clinic?’ In 2011, the questionnaire
was posted with a paid return envelope to the last
known address of all attendees of the pre-pregnancy
counselling clinic between 2003 and 2011 (n = 179). The
questionnaire was sent to the women with an invitation
to participate in the study including the purpose of the
study, why the recipient had been chosen, the voluntary
nature of participation and the anonymity of the re-
sponse. Contact details were clearly stated. Informed
consent was indicated by the return of the completed
questionnaire. The fixed question data was analysed
descriptively. The free text data was analysed using the-
matic content analysis methods [10]. All comments were
read and key emergent themes were noted by two of the
authors (KW, CT) independently. A final thematic
coding framework was agreed and applied to all com-
ments. The coding framework was informed by the
Institute of Medicine dimensions of patient centred care
[8] which underpinned the design of the questionnaire,
but was also driven by the data itself and allowed to ex-
tend or challenge the Institute of Medicine dimensions
as required.
Our hospital database was retrospectively interrogated
for maternity outcome data that had previously been
collected during the course of normal patient care. Preg-
nancy outcomes were available for women who had
attended pre-pregnancy counselling and subsequently
delivered at St. Thomas’ Hospital (n = 35). Outcomes
included:
 Pre-eclampsia: Documented diagnosis in the hospital
database
 Fetal growth restriction: <10th centile for gestational
age [11]
 Preterm delivery: <37 weeks’ gestation
 Intrauterine death: >24 weeks’ gestation
 2nd trimester miscarriage: 14 - <24 weeks’ gestation
 Pregnancy loss: 2nd trimester miscarriage or
intrauterine death
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Pregnancy outcomes were compared to a control co-
hort of 277 women delivering at our hospital over the
same time period (January 2005-July 2011) previously
reported elsewhere [12]. This control population was
representative of a tertiary referral obstetric population
with 18% prevalence of chronic disease, excluding pre-
existing renal disease, hypertension and diabetes. Fisher’s
exact test was used for bivariate comparison of dicho-
tomous data.
Ethics statement
This manuscript describes a service evaluation and did
not require formal NHS Research Ethics Committee re-
view. The study was designed to measure current care
with the aim of establishing the standard of pre-pregnancy
counselling for women with CKD at a single tertiary
centre, with results that would not be generalizable out-
side the assessed area of practice. The analysis of existing
data was performed by the direct care health team and
subsequently anonymised.
The ethical nature of this evaluation was considered
justified on the basis that there was no deviation
from normal clinical practice. In addition participants
were informed of the rationale for the study, the vol-
untary nature of the questionnaire and the anonymity
of their response with informed consent being given
by return of the questionnaire.
Other than the time taken to complete and return
the questionnaire there was no additional burden or
risk for participants. Although there are no explicit
criteria for pre-pregnancy counselling, our use of the
2001 Institute of Medicine dimensions of patient care
meant that this study was registered and approved as
an audit at Guy’s and St. Thomas’ NHS Foundation
Trust.
Results
Demographics and clinical presentation of women
attending the clinic
179 women with CKD attended for pre-pregnancy coun-
selling between 2003–2011. There was a trend for an in-
creasing number of referrals over time (see Additional
file 2: Figure S1). Age ranged from 21–46 years with a
median of 33 years. 131 women (73%) were nulliparous.
The 179 women had 236 diagnoses (see Table 1). The
median number of diagnoses per patient was 1 al-
though some women had more than one diagnosis with
the potential to impact a pregnancy (range 1–3), for
example, diabetic nephropathy and subsequent trans-
plantation, or hypertensive nephropathy with secon-
dary glomerulosclerosis.
The severity of renal impairment pre-pregnancy ranged
from CKD stage 1–5 (see Table 2).
Pre-pregnancy blood pressure records were available
for 167 women (93% of cohort). 56 (34%) were normo-
tensive without treatment (<140/90 mmHg), 89 (53%)
had controlled blood pressure on anti –hypertensive
medication and 22 (13%) had uncontrolled blood pres-
sure (>140 or >90mmgHg) despite treatment. 77 women
(43%) had detectable proteinuria and 18 women (10%)
had a history of nephrotic-range proteinuria (>3 g/
24 hours).
Medication data were available for 175 women: 85
women (49%) were counselled regarding a required
change in medication for pregnancy including discon-
tinuation and/or substitution of angiotensin receptor
blockade in 46 women (26%) and mycophenolate mofetil
in 33 women (19%). Other medications of relevance to
pregnancy included bisphosphonates, diuretics, warfarin,
statins and tetracycline.
Questionnaire data
72 women responded to the questionnaire (response rate
40%). 65 women (90%) stated that they found the clinic
informative, 66 women (92%) reported that they under-
stood the advice given and 64 women (89%) felt that the
consultation had helped them decide about pursuing
Table 1 Diagnoses in women attending for pre-pregnancy
counselling
Diagnosis Number of patients (%)*
Glomerulonepritis (not lupus) 41 (17)
Lupus nephritis 28 (12)
FSGS and other nephrotic syndromes 33 (14)
Reflux nephropathy 30 (13)
Diabetic nephropathy 20 (8)
Hypertensive nephropathy 13 (6)
Inherited/congenital renal disease 10 (4)
Renal stone disease 4 (2)
Other 3 (1)
Kidney transplant 41 (17)
Kidney-pancreas transplant 13 (6)
*236 diagnoses in 179 patients (123 patients with single diagnosis, 52 patients
with 2 diagnoses and 3 patients with 3 diagnoses).
Table 2 CKD stage in the pre-pregnancy counselling
cohort
CKD Stage eGFR ml/min/1.73 m2 Number of patients (%)
1 >90 50 (30%)
2 60- < 90 48 (27%)
3A 45- < 60 32 (18%)
3B 30- < 45 31 (17%)
4 15- < 30 16 (9%)
5 <15 or dialysis 2 (1%)
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pregnancy. Although 64 women (89%) felt that it was
helpful to see three specialists together, 12 women (17%)
felt that the presence of many doctors was intimidating.
42/72 (58%) of the respondents provided free text data.
31/42 (74%) provided positive comments, 6/42 (14%)
were mixed and 5/42 (12%) were negative. Key themes
were the expertise and professionalism of the multidis-
ciplinary team, provision of information and understan-
ding, access to services, decision-making, the emotional
response to the consultation and provision of individua-
lised care (see Table 3).
Pregnancy outcomes
Outcome data were available for 35 women who at-
tended pre-pregnancy counselling and subsequently de-
livered at St. Thomas’ Hospital. Prior to pregnancy,
these women had CKD stages 1-3B. Rates of pre-
eclampsia, intrauterine growth restriction, preterm birth,
intrauterine death and mid-trimester miscarriage were
significantly higher for women with CKD compared to
our control population (see Table 4).
Discussion
This analysis of women attending a pre-pregnancy
counselling renal clinic has identified that women had
substantial comorbidity that will influence pregnancy
outcomes and half were taking teratogenic medication.
The majority of women found the clinic to be infor-
mative and felt that it influenced decision-making. Sub-
sequent pregnancies had high rates of maternal and fetal
complications compared with controls, despite attempts
to optimise maternal heath in the pre-pregnancy setting.
This supports the need for accurate and detailed in-
formation of pregnancy outcomes to be discussed prior
to pregnancy, in order to facilitate informed decision-
making about conception.
CKD affects up to 3% of women aged 20–39 years
[13]. Between 2003 and 2011, 179 women with CKD
from the South East of England were referred for pre-
pregnancy counselling to our specialised clinic. There
was an increase in referrals over the last decade which is
likely to reflect trends of older primiparity [14], obesity
[15] and advances in fertility treatment resulting in more
pregnancies being complicated by CKD [16].
The need for pre-pregnancy counselling in women with
CKD is well recognised by health professionals [3,5] and
this is supported by our data. The majority of women were
nulliparous with no obstetric history to inform assessment
of their pregnancy-associated risk, therefore expert indi-
vidual risk assessment based on comorbidity was ne-
cessary. Women attending pre-pregnancy counselling had
complex renal diagnoses, and up to one third had a renal
Table 3 Content analysis of questionnaire free text data
Theme Number of
comments
Positive Negative Examples
Expertise/Professionalism 23 23 0 • We felt very lucky to have been referred and have the opportunity to talk with a
panel of consultants
• It was fantastic to feel we had the best of advice in all areas and that a specialist
from all areas was there
• Three consultants were extremely well informed and we found their opinion and
level of expertise both beneficial and reassuring
Information/understanding 20 18 2 • If we had any questions or didn’t understand they clarified things
• It enabled me to understand the condition of my kidneys and to accept the
problems I might be facing
• I decided not to go through with it and I’m not sure that’s right
Access to services 13 11 2 • It felt like it took a long time to reach the right people
• Letter was useful with both pregnancies at local hospital
Decision-making 12 10 2 • It is an important decision and it was – and still is – very reassuring to know that
the decision we took was with the best information
• If it had not been for the clinic and reassurance from consultants that it was safe to
fall pregnant we probably would not have tried
Emotional response 9 4 5 • I found this quite stressful and frightening
• The risks scared me so much
• It made me feel safe
Individualised care 7 5 2 • I have other medical problems as well and the doctors were able to give me some
very informed advice
• All concerns were taken seriously
• My thoughts and view were not taken into consideration
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transplant. The severity of renal disease was diverse and
nearly half had CKD Stages 3–5.
Although the severity of CKD is the major determin-
ant of pregnancy-related risk, adverse outcome rates are
higher even in women with CKD Stage 1 and normal
glomerular filtration, compared to controls [3,17]. How-
ever, women with CKD Stages 1–2 have a reduced likeli-
hood of adverse events compared to women with more
advanced disease [1].
The association between hypertension and pregnancy-
related complications is well recognised [18,19]. Women
with hypertension have a substantially higher risk for the
development of pre-eclampsia compared to normoten-
sive women with the same glomerular filtration rate
(GFR) [20], and uncontrolled hypertension in early preg-
nancy is associated with poor outcomes [21]. Conversely
normotension is a strong predictor of good pregnancy
outcomes [22]. Two-thirds of our pre-pregnancy cohort
required treatment for blood pressure control and one
in eight women had uncontrolled hypertension despite
treatment, emphasising the importance of tailored pre-
pregnancy care.
Severity of proteinuria is also associated with un-
favourable pregnancy outcomes in some cohorts [23-25].
Just under half the women attending pre-pregnancy
counselling had detectable proteinuria. Pregnant women
with CKD are at risk of developing significant protein-
uria due to increased glomerular filtration and altered
renal protein handling, even when proteinuria is not
present before pregnancy [26]. Women with CKD need
to be informed about exacerbation of proteinuria in
pregnancy and implications for thromboprophylaxis and
diagnostic uncertainty in the context of pre-eclampsia.
Pre-pregnancy counselling enables screening of medi-
cation for teratogenicity. First trimester exposure to
angiotensin-converting enzyme (ACE) inhibitors leads to
an increase in congenital malformation, and exposure in
the second and third trimesters leads to a recognised
fetopathy [7,27]. Angiotensin receptor blockade (ARB) is
also associated with adverse fetal effects [28]. Over one
quarter of the women with CKD who attended for pre-
pregnancy counselling were prescribed either ACE
inhibitors and/or ARBs. Counselling with regard to
the timing of drug discontinuation and instruction for
requantification of proteinuria, represented a consi-
derable component of the pre-pregnancy counselling
process.
Approximately one fifth of women were taking myco-
phenolate mofetil, which is also a recognised teratogen
[29]. Substitution with azathioprine and confirmation of
stable disease is recommended prior to pregnancy [3].
Data concerning the maternal renal consequences of this
drug replacement are reassuring in both renal trans-
plantation and women with stable lupus nephritis [30].
Despite recommendations for pre-pregnancy counsel-
ling, there are limited data regarding the optimum way
to deliver this service. The multidisciplinary model pre-
sented here includes a consultant obstetric physician,
obstetrician and nephrologist offering counselling to
women and their partners. The questionnaire identified
that women were satisfied with this process and the
provision of information. Subjective levels of under-
standing were excellent and decision-making regarding
pregnancy was facilitated for the majority. Access was
however highlighted by the women. Pathways into the
clinic, and to other specialists, need to be examined in
order to ensure that individualised pre-pregnancy care is
achieved for all women according to demand.
17% of the women found the pre-pregnancy counselling
process intimidating in the format of a ‘panel’ of three
doctors. This structure contrasts with other multidiscip-
linary models in the UK. For example the well-established
multidisciplinary format of cancer care involves relevant
professions meeting in the absence of the patient aiming
to facilitate unbiased discussion [31]. This model removes
some elements that are likely to contribute to a feeling of
intimidation. However, patient autonomy is dependent on
the clarity, consistency and completeness of information,
and the cancer model does have recognised deficiencies in
patient communication and the provision of information
[32]. Our multidisciplinary model allows women’s views
and preferences to explicitly inform decision-making and
promotes autonomy via the provision of an immediate re-
source of expertise.
At St. Thomas’ Hospital, antenatal care for women
with CKD is provided by the same clinicians who deliver
pre-pregnancy counselling. Anecdotally, it was felt that
having prepared women for the possibility of adverse
Table 4 Pregnancy outcomes in women attending for pre-pregnancy counselling
Adverse outcome All n = 35 CKD stage 1–2 n = 23 CKD stage 3 n = 12 Controls n = 277
Pre-eclampsia 7 (20%)** 4 (17%)** 3 (25%)** 11 (4%)
Small for gestational age 8 (23%)** 6 (26%)** 2 (17%)** 29 (10%)
Preterm <37 weeks 11 (31%)** 5 (22%)** 6 (50%)** 21 (8%)
Preterm <34 weeks 4 (11%)** 2 (9%)** 2 (17%)** 4 (1%)
IUD/Mid-trimester miscarriage 5 (14%)** 3 (13%)** 2 (17%)** 7 (3%)
**p < 0.01.
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outcomes, women who had received pre pregnancy
counselling were not as shocked or upset when compli-
cations arose as those who had not received counselling.
In addition, content analysis of the questionnaire free
text data revealed that three women (4% of responding
cohort) had opted not to attempt a pregnancy following
pre-pregnancy counselling. These factors reveal the im-
portance of a risk assessment for women with CKD con-
templating pregnancy. The communication of risk can
reduce the incidence of complications if women opt not
to conceive, as well as the psychological impact if com-
plications do occur. However, the patient’s emotional re-
sponse to the consultation needs to be acknowledged
and supported.
Conclusion from this study is limited by a response
rate of only 40%, which means that responder bias can-
not be excluded. In addition, recall bias is a factor, espe-
cially for those women who attended clinic in the earlier
years of the study. Qualitative research within the field
of pre-pregnancy counselling is limited and validated
questionnaires do not exist in published literature. The
questionnaire used in this study was piloted prior to
use, and underpinned by an established framework of
patient-centred care. However, the structured design
with categorical responses may not have allowed women
to express fully their experience, and the questionnaire
may therefore lack validity. Although free text was in-
vited and did show consensus with the discrete data, this
was not completed by all respondents. Further develop-
ment and validation of a measure to assess the experi-
ence of pre-pregnancy care for women with CKD would
be valuable. Mixed method research including qua-
litative methods, would help to define domains of the
pre-pregnancy counselling experience from the patient’s
perspective, thereby validating and informing future
research within this field.
This study confirms that adverse pregnancy outcomes
in women with CKD are more common than tertiary
hospital controls. A limitation of the study was establish-
ing a formal diagnosis of pre-eclampsia, which is chal-
lenging in both clinical and research settings [33],
particularly in women with CKD. Furthermore, hospital
databases frequently under-report this complication [34].
Despite this, the incidence of pre-eclampsia in our
cohort was high (20%). Preterm delivery (<37 weeks) oc-
curred in half of the women with CKD Stages 3A or 3B
and approximately one in seven pregnancies was lost
after the first trimester. Data were only available for de-
liveries at St. Thomas’ Hospital and referral bias is pos-
sible, with high risk women being advised to book for
tertiary level antenatal care, and women with complica-
tions being transferred in antenatally. However, when
compared to a control population with non-renal co-
morbidity also delivering at St. Thomas’ Hospital over
the same time period; rates of pre-eclampsia, intrauter-
ine growth restriction, preterm birth, intrauterine death
and mid-trimester miscarriage were significantly higher
for women with CKD. In addition, outcome data from
this study are consistent with other series, which show
comparable rates of pre-eclampsia (22%), preterm deli-
very (30%) and fetal growth restriction (25%) in women
with a serum creatinine >125 μmol/l, which equates
roughly to CKD Stage 3 [1].
Another limitation of the study is the lack of a formal
comparison between those who have and have not
attended a pre-pregnancy counselling clinic. However, a
randomized study would not be ethical and a robust
retrospective evaluation of whether women had received
counselling prior to pregnancy by a different team is not
possible. It is possible that pre–pregnancy counselling
may prevent some adverse outcomes by ensuring opti-
misation of pre-pregnancy blood pressure and replace-
ment of teratogenic medications, and this should be
studied prospectively.
Conclusions
There is a growing requirement for renal pre-pregnancy
counselling services and this is the first study of accept-
ability and the impact from the perspective of women
with CKD. This study offers evidence that a specialist
clinic provides high levels of patient satisfaction. Due to
advances in medical care, complex renal diagnoses exist
with increasing frequency in women of childbearing age.
Hypertension, proteinuria and teratogenic medications
are prevalent in these women and need to be optimised
before pregnancy. In addition, maternal and neonatal ad-
verse outcomes are common in pregnant women with
CKD and shared-decision making is only possible if that
risk is understood and communicated effectively. This
study provides proof of concept that there is a need for
and value to pre-pregnancy counselling in allowing
women to make an informed decision regarding preg-
nancy as well as preparing them for possible and likely
complications.
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